Definitive Contract W81XWH19C0145
Award Date 9/20/19
Potential Completion Date 9/19/22
Potential Value $3.4M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price Level of Effort
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal research and development contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Sanaria Inc., a biotechnology company, for the development of a multi-strain malaria vaccine. The contract has a total potential value of $2,799,216.00 and is a definitive contract with a cost-no-fee pricing type. The contract does not have a set-aside designation and is set to be completed by July 18, 2019. Sanaria Inc. has previously provided services to support malaria...
- This is a $9,468,085.00 firm fixed-price definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Sanaria Inc., a for-profit, veteran-owned business, for the Phase II development of a malaria vaccine. The contract, which is not set aside, is focused on the continued research, development, and manufacturing of Sanaria's investigational Plasmodium falciparum sporozoite (PfSPZ) vaccine. This includes process improvements, non-clinical studies, and clinical trials in the U.S.,...
- This is a $5,699,486.00 federal contract award from the Bureau of Medicine and Surgery, a defense agency, to Sanaria Inc., a for-profit, veteran-owned business and manufacturer. The contract is for research and development services, with a performance period ending on October 31, 2018. Sanaria Inc. has provided services such as asexual malaria blood culture, clinical trial services for an investigational malaria vaccine, and research and development of P. falciparum sporozoite vaccines. This...
- This $303,590.36 firm fixed price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Sanaria Inc., a for-profit organization and veteran-owned business that manufactures goods. The contract is for a 24-month malaria culture service to provide asexual malaria blood stage cultures and enriched late-stage gametocyte cultures to support malaria drug development efforts. This award is not associated...
- This is a $999,997.00 firm fixed-price SBIR Phase II R&D contract awarded by the Defense Health Agency (DHA) to Sanaria Inc., a small business veteran-owned manufacturer. The contract is for the "Delivery System for Cryopreserved Eukaryotic Cell Vaccines," supporting Sanaria's work on an investigational malaria vaccine using Plasmodium falciparum sporozoites. Sanaria has previously received federal funding for malaria vaccine research, development, and manufacturing from agencies...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Sanaria Inc., a biotechnology company focused on the development of malaria vaccines. The $149,931.25 firm-fixed-price purchase order is for the delivery of purified, vialed, and cryopreserved products, with a period of performance ending on February 29, 2016. Sanaria Inc. has previously received federal grants and contracts related to the research, development, and...
- The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $64,000.00 firm fixed price purchase order contract to Sanaria Inc., a biotechnology company that specializes in malaria vaccine development. The contract is for the procurement of Sanaria's PfSPZ Reagent biological kits, which will be used for ongoing clinical trial experiments at the Laboratory of Immunogenetics (LIG) to study immune interactions with peripheral blood...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Sanaria Inc., a veteran-owned biotechnology company, for the development of a "Delivery System for Cryopreserved Eukaryotic Cell Vaccines." The potential value of this definitive, firm fixed-price contract is $149,994.23. Sanaria Inc. has prior experience providing services to support malaria drug development and vaccine clinical trials for federal agencies...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $89,054.88 firm fixed price purchase order to Sanaria Inc. to provide asexual malaria blood culture service. The contract calls for monthly delivery of Plasmodium falciparum asexual parasites at over 90% ring stage, complete culture medium, and human blood for use in the National Center for Translational Sciences' malaria viability assays to support...
- <p>This is a $148,402.94 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Sanaria, Inc. under the Small Business Innovation Research (SBIR) Phase II program. The contract is for "Delivery System for Cryopreserved Eukaryotic Cell Vaccines" research and development work, with a completion date of January 10, 2019. The contract was set aside for small businesses.</p>